The purpose of the present multicentric study was to review stereotactic body radiotherapy (SBRT) with or without chemotherapy (CHT) experience in locally advanced pancreatic cancer (LAPC). Endpoints were overall survival (OS), local control (LC), and distant metastasis-free survival (DMFS). Several parameters' impact on these outcomes was assessed.
Arcelli, A., Guido, A., Buwenge, M., Simoni, N., Mazzarotto, R., Macchia, G., et al. (2020). Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). ANTICANCER RESEARCH, 40(1), 465-472 [10.21873/anticanres.13975].
Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1)
Arcelli, Alessandra;Guido, Alessandra;Buwenge, Milly;Grassi, Elisa;DI Marco, Mariacristina;Casadei, Riccardo;Morganti, Alessio G;Cammelli, Silvia
2020
Abstract
The purpose of the present multicentric study was to review stereotactic body radiotherapy (SBRT) with or without chemotherapy (CHT) experience in locally advanced pancreatic cancer (LAPC). Endpoints were overall survival (OS), local control (LC), and distant metastasis-free survival (DMFS). Several parameters' impact on these outcomes was assessed.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
